PINK1 and non-small cell lung carcinoma: The downregulation of PINK1 can enhance cisplatin- (CDDP-) induced apoptosis in NSCLC cells [18] and makes cervical cancer cells (including HeLa and BT474 cells) sensitive to paclitaxel, significantly increasing cell death [21].